Prolytic GmbH   Report issue

For profit Phase 1
Founded: Frankfurt Germany (2002)

Organization Overview

First Clinical Trial
2010
NCT01190852
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (2)

azelastine (astelin) (2 trials)

fluticasone (cutivate) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Rhinitis (Phase 1)

Rhinitis, Allergic (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 2